Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
Year: 2012
Type: review
Source: Endocrine Reviews
DOI: 10.1210/er.2011-1060
Institution: Amgen (United States)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, UCB Pharma
OpenAlex ID: W2118492754